Vaccination against oncofetal targets in the tumor vasculature
Mice were vaccinated with iBoost technology against a tumor vascular target, prior to B16F10 or CT26 tumor inoculation. Tumors from control and target vaccinated mice were excised and subject to RNAseq Overall design: mRNA profiles of target and control vaccinated mice' B16F10 and CT26 tumor tissue